These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34193275)

  • 1. Digoxin absorption decreased independently of P-gp activity in rats with irinotecan-induced gastrointestinal damage.
    Tsuchitani T; Akiyoshi T; Imaoka A; Ohtani H
    J Pharm Health Care Sci; 2021 Jul; 7(1):24. PubMed ID: 34193275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irinotecan-induced gastrointestinal damage impairs the absorption of dabigatran etexilate.
    Hattori T; Imaoka A; Akiyoshi T; Ohtani H
    Biopharm Drug Dispos; 2019 Nov; 40(9):315-324. PubMed ID: 31642538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluororacil-Induced Gastrointestinal Damage Impairs the Absorption and Anticoagulant Effects of Dabigatran Etexilate.
    Tsujii K; Hattori T; Imaoka A; Akiyoshi T; Ohtani H
    J Pharm Sci; 2018 May; 107(5):1430-1433. PubMed ID: 29291414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced physiologically-based pharmacokinetic model of dabigatran etexilate-dabigatran and its application for prediction of intestinal P-gp-mediated drug-drug interactions.
    Lang J; Vincent L; Chenel M; Ogungbenro K; Galetin A
    Eur J Pharm Sci; 2021 Oct; 165():105932. PubMed ID: 34260894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoprotein.
    Liang Y; Zhou Y; Zhang J; Liu Y; Guan T; Wang Y; Xing L; Rao T; Zhou L; Hao K; Xie L; Wang GJ
    Phytomedicine; 2013 Aug; 20(11):1030-8. PubMed ID: 23731657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats.
    Zhang H; Yao M; Morrison RA; Chong S
    Arch Pharm Res; 2003 Sep; 26(9):768-72. PubMed ID: 14560928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats.
    Song S; Suzuki H; Kawai R; Sugiyama Y
    Drug Metab Dispos; 1999 Jun; 27(6):689-94. PubMed ID: 10348798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil treatment alters the expression of intestinal transporters in rats.
    Yotsumoto K; Akiyoshi T; Wada N; Imaoka A; Ohtani H
    Biopharm Drug Dispos; 2017 Dec; 38(9):509-516. PubMed ID: 28849584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity.
    Guan HY; Li PF; Wang XM; Yue JJ; He Y; Luo XM; Su MF; Liao SG; Shi Y
    Front Pharmacol; 2017; 8():769. PubMed ID: 29163158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of rat intestinal P-glycoprotein by spironolactone and its effect on absorption of orally administered digoxin.
    Ghanem CI; Gómez PC; Arana MC; Perassolo M; Delli Carpini G; Luquita MG; Veggi LM; Catania VA; Bengochea LA; Mottino AD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1146-52. PubMed ID: 16740618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of gastrointestinal absorption of digoxin involving influx and efflux transporter in rats: application of mdr1a knockout (-/-) rats into absorption study of multiple transporter substrate.
    Suzuki M; Komura H; Yoshikawa T; Enya S; Nagao A; Takubo H; Kogayu M
    Xenobiotica; 2014 Nov; 44(11):1039-45. PubMed ID: 24839994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a quantification method for digoxin, a typical P-glycoprotein probe in clinical and non-clinical studies, using high performance liquid chromatography-tandem mass spectrometry: the usefulness of negative ionization mode to avoid competitive adduct-ion formation.
    Hirabayashi H; Sugimoto H; Matsumoto S; Amano N; Moriwaki T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(32):3837-44. PubMed ID: 22098716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions.
    Zhang J; Zhou F; Wu X; Gu Y; Ai H; Zheng Y; Li Y; Zhang X; Hao G; Sun J; Peng Y; Wang G
    Drug Metab Dispos; 2010 Dec; 38(12):2179-87. PubMed ID: 20837659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide.
    Yang XX; Hu ZP; Chan SY; Duan W; Ho PC; Boelsterli UA; Ng KY; Chan E; Bian JS; Chen YZ; Huang M; Zhou SF
    Curr Drug Metab; 2006 May; 7(4):431-55. PubMed ID: 16724931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the relative contribution of CYP3A-and P-gp-mediated pathways to the overall disposition and drug-drug interaction of dabigatran etexilate using a comprehensive mechanistic physiological-based pharmacokinetic model.
    Udomnilobol U; Dunkoksung W; Sakares W; Jianmongkol S; Prueksaritanont T
    Front Pharmacol; 2024; 15():1356273. PubMed ID: 38515840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of itraconazole on the pharmacokinetics of digoxin in guinea pigs.
    Nishihara K; Hibino J; Kotaki H; Sawada Y; Iga T
    Biopharm Drug Dispos; 1999 Apr; 20(3):145-9. PubMed ID: 10211867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Role of P-glycoprotein (P-gp)-Mediated Efflux in the Intestinal Absorption of Common Substrates with Elacridar, a P-gp Inhibitor, in Rats.
    Suzuki K; Taniyama K; Aoyama T; Watanabe Y
    Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):385-392. PubMed ID: 32078103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein.
    Bansal T; Awasthi A; Jaggi M; Khar RK; Talegaonkar S
    Life Sci; 2008 Aug; 83(7-8):250-9. PubMed ID: 18619980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in digoxin pharmacokinetics associated with hepatic P-glycoprotein upregulation in rats with non-alcoholic fatty liver disease.
    Jeong HJ; Lee SH; Kang HE
    Fundam Clin Pharmacol; 2021 Dec; 35(6):1100-1108. PubMed ID: 33914974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats.
    Kurita A; Kado S; Kaneda N; Onoue M; Hashimoto S; Yokokura T
    Cancer Chemother Pharmacol; 2000; 46(3):211-20. PubMed ID: 11021738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.